Status:

COMPLETED

Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication

Lead Sponsor:

Nissan Chemical Industries

Conditions:

Intermittent Claudication

Peripheral Vascular Disease

Eligibility:

All Genders

50+ years

Phase:

PHASE2

Brief Summary

NM-702 oral tablets are being developed for the treatment of Intermittent Claudication, a primary early stage indication of peripheral arterial disease (PAD). This trial is designed to assess the safe...

Detailed Description

NM-702 oral tablets are being developed for the treatment of Intermittent Claudication, a primary early stage indication of peripheral arterial disease (PAD). This trial is designed to assess the safe...

Eligibility Criteria

Inclusion

  • Stable, symptomatic, intermittent claudication due to occlusive atherosclerotic disease of the lower extremities
  • Median treadmill peak walking time between 90 and 600 seconds

Exclusion

  • Symptoms of limb threatening ischemia (ischemic rest pain, ischemic ulceration and/or gangrene)
  • Clinically significant pulmonary, neurological or skeletal dysfunction (e.g., lumbar canal stenosis, emphysema, uncontrolled angina, multiple sclerosis, or gait altering amputation) that would directly interfere or limit exercise testing
  • Subjects who have had, or will require, a peripheral revascularization procedure within 12 weeks prior to or following treatment initiation.
  • A resting blood pressure greater than 150/100 and other clinically significant results.

Key Trial Info

Start Date :

April 1 2003

Trial Type :

INTERVENTIONAL

End Date :

April 1 2006

Estimated Enrollment :

390 Patients enrolled

Trial Details

Trial ID

NCT00102050

Start Date

April 1 2003

End Date

April 1 2006

Last Update

May 19 2006

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Investigator

Long Beach, California, United States, 90822

2

Investigator

Riverside, California, United States, 92501

3

Investigator

San Diego, California, United States, 92121

4

Investigator

San Francisco, California, United States, 94121